BP004608: Mouse LCAT Protein with the C-His Tag
Source: The recombinant Mouse LCAT Protein, (amino acids Phe25-Glu438) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000470-PRO-317: Human Coagulation Factor-VIII (FVIII) Protein
Source: Human Plasma-derived.
The potency per mg of Human Coagulation Factor-VIII was tested and found to be 150 Units/mg.BP000470-PRO-318: Recombinant Human Coagulation Factor-VIII (FVIII) Protein
Source: CHO cells-derived.
The specific activity of recombinant human FVIII Protein was found to be 7428 IU/mg.
Purity: > 97.0% as determined by SDS-PAGE.C017: ReFacto Biosimilar Stable Cell Line (CHO)
The yield of ReFacto biosimilar from the CHO stable cell line was above 60 IU/mL in a 50 liter manufacturing.
C018: Advate / Kogenate Biosimilar Stable Cell Line
The yield of Advate / Kogenate Biosimilar from the CHO stable cell line was above 60 IU/ml in a 50 liter manufacturing.
C056P: Teplizumab Biosimilar, CD3 Monoclonal Antibody
Recombinant human IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade teplizumab biosimilar specifically binds to the human T cell receptor CD3.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by teplizumab.C018: Advate / Kogenate Biosimilar Stable Cell Line
The yield of Advate / Kogenate Biosimilar from the CHO stable cell line was above 60 IU/ml in a 50 liter manufacturing.